Statins lower cholesterol by blocking an enzyme in your liver that produces it, which forces your liver to pull more cholesterol out of your bloodstream. That’s their primary job, but they do quite a bit more throughout your body, some of it beneficial and some of it worth watching. Most people notice their LDL (“bad”) cholesterol drop significantly within one to three months of starting a statin.
How Statins Lower Cholesterol
Your liver manufactures most of the cholesterol in your body using a specific production pathway. Statins block an early step in that pathway, shutting down an enzyme your liver needs to make cholesterol. With its own production cut off, your liver compensates by pulling LDL cholesterol from the blood more aggressively. It does this by increasing the number of receptors on its surface that grab onto LDL particles floating past.
The result is a measurable drop in the amount of LDL circulating in your bloodstream. By the three-month mark, you’re seeing the full cholesterol-lowering effect regardless of which statin you’re on. High-intensity statins can cut LDL by 50% or more, while moderate-intensity versions typically reduce it by 30% to 49%.
Effects Beyond Cholesterol
Statins do more than just lower a number on your blood test. They improve the health of the tissue lining your blood vessels by boosting the production of nitric oxide, a molecule that helps arteries relax and stay flexible. They also reduce inflammation inside artery walls, decrease the stickiness of platelets (making dangerous clots less likely), and can stabilize existing plaques so they’re less prone to rupturing. A ruptured plaque is what triggers most heart attacks and strokes.
These “bonus” effects happen because the same production pathway statins block doesn’t just make cholesterol. It also produces small signaling molecules that drive inflammation, oxidative stress, and blood vessel stiffness. When statins shut down the pathway, all of those downstream products drop too. This is a major reason statins reduce heart attack and stroke risk by more than you’d expect from the cholesterol reduction alone.
What Happens to Your Muscles
Muscle symptoms are the most commonly reported side effect. People describe aching, soreness, weakness, or cramping, usually in the large muscle groups like thighs, calves, and upper arms. The discomfort tends to be symmetrical, affecting both sides of the body.
One reason this happens traces back to the same blocked production pathway. In addition to cholesterol, that pathway produces a molecule called CoQ10 (coenzyme Q10), which your cells use to generate energy. Statins reduce CoQ10 levels in the body. Muscles are energy-hungry tissue, so they may feel the impact more than other cells. Whether taking a CoQ10 supplement relieves statin-related muscle pain is still debated, with mixed results in clinical studies, but some people find it helpful.
It’s worth noting that in large blinded trials, where neither patients nor doctors knew who was taking the real drug, muscle complaints were far less common than in real-world reports. This suggests that some muscle pain attributed to statins may come from other causes or from the expectation of side effects. Still, for the people who genuinely experience it, the discomfort is real and sometimes significant enough to require switching medications or adjusting the dose.
Effects on Blood Sugar
Statins can nudge your blood sugar higher. A large meta-analysis published in The Lancet Diabetes & Endocrinology found that high-intensity statin therapy increased the rate of new diabetes diagnoses by 36% compared to placebo. That sounds alarming as a percentage, but the absolute risk is modest: for most people, it means a small increase in fasting glucose that may or may not cross the threshold for a diabetes diagnosis.
Researchers are still working out exactly why this happens. One emerging explanation involves changes to the gut microbiome. Statin use appears to shift the balance of certain bacterial species in the intestines, which can alter the production of metabolites that affect insulin sensitivity. Specifically, some of these microbial changes may reduce short-chain fatty acids (which help regulate blood sugar) and increase compounds that promote insulin resistance. Disruption of the intestinal barrier may also allow inflammatory molecules into the bloodstream, further worsening glucose control.
For most people, the cardiovascular benefits of statins outweigh this modest diabetes risk. But if you already have prediabetes or other risk factors, your doctor may monitor your blood sugar more closely after starting therapy.
Your Liver on Statins
Because statins work primarily in the liver, there was long-standing concern about liver damage. In practice, serious liver injury from statins is extraordinarily rare: roughly 2 cases or fewer per one million patient-years of use. Some people do see a mild bump in liver enzymes on blood tests, but this usually resolves on its own and doesn’t indicate actual liver damage.
The FDA and the National Lipid Association concluded that routine periodic monitoring of liver enzymes in people without symptoms isn’t supported by evidence, since it doesn’t appear to detect or prevent the rare cases of serious injury. Most guidelines now recommend checking liver function before starting a statin rather than repeatedly afterward.
Statins and Your Brain
Some people report feeling foggy or having memory lapses after starting a statin, and the FDA added a warning about this in 2012. The concern makes biochemical sense for certain statins: simvastatin, atorvastatin, lovastatin, and fluvastatin are fat-soluble enough to cross the blood-brain barrier, while pravastatin is water-soluble and largely stays out.
However, large-scale evidence hasn’t confirmed that statins cause lasting cognitive decline. A few smaller studies actually found that atorvastatin had a positive effect on cognition in patients with Alzheimer’s disease, though the evidence isn’t strong enough to recommend statins as a treatment for dementia. If you notice memory issues after starting a statin, it’s reasonable to discuss switching to a water-soluble option, but the overall risk of meaningful cognitive harm appears low.
Who Is Recommended to Take Them
Current guidelines from the American Heart Association and American College of Cardiology use a 10-year cardiovascular risk score to guide decisions. Adults are grouped into four categories: low risk (under 5%), borderline (5% to under 7.5%), intermediate (7.5% to under 20%), and high (20% or above). Statins are most clearly recommended for people in the intermediate and high categories, and for most adults aged 40 to 75 with diabetes, who typically fall into those brackets.
For people in the borderline range, the decision often comes down to additional factors like coronary artery calcium scores, family history, or the presence of other conditions that tip the scales. Even generic statins have been shown to be cost-effective at the lower end of the intermediate range, which is why they remain one of the most widely prescribed drug classes in the world.
The Timeline of Changes
After you start a statin, changes begin quickly but aren’t instant. Cholesterol levels start dropping within the first few weeks. By one to three months, you’re seeing the full effect on your LDL numbers, and this is typically when your doctor will recheck your bloodwork to see how well the dose is working.
Plaque stabilization, the process of making existing buildup in your arteries less likely to rupture, begins in the same timeframe but continues to improve over months and years. Actual regression of plaque, where deposits shrink, takes longer and is more likely with high-intensity therapy sustained over years. The cardiovascular protection from statins is cumulative: the longer you take them, the more benefit accrues, which is why stopping abruptly can be counterproductive.